The
USP has proposed a new standard for bioburden testing (USP chapter 1115). The
main basis of the chapter is setting out a risk based approach to monitor and
control a manufacturing facility for the processing of non-sterile products.
To
examine the implications of the proposed chapter, and in a review of bioburden
issues in general, Tim Sandle has written an article for the GMP Review.
The
reference is:
Sandle,
T. (2013). A new standard for bioburden testing: USP chapter in development, GMP Review, 12 (3): 10-12
Posted by Tim Sandle
No comments:
Post a Comment
Pharmaceutical Microbiology Resources